6550--Notice of Intent to Sole-Source T-SPOT.TB® Reagents and Kits
Active
36C24227Q0036FederalResponse Deadline
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
General Info
Place of Performance
NYSet-Aside
NONE
Documents
2AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Response Deadline
Organization & Contact Information
Show more
AgencyDepartment Of Veterans Affairs → 242-NETWORK Contract Office 02 (36C242)
Contacts1 person available
OfficeALBANY, NY, 12208, USA
Organization / AgencyDepartment Of Veterans Affairs → 242-NETWORK Contract Office 02 (36C242)
Office AddressALBANY, NY, 12208, USA
Contacts
Full Description
Show more
This notice is being published in accordance with Revolutionary FAR Overhaul Federal Acquisition Regulation (RFO FAR) Subpart 5.101 requiring dissemination of information for proposed contract actions.
The Department of Veterans Affairs, Network Contracting Office (NCO) 2, hereby provides notice of its intent to award a sole source, firm fixed price contract to Euroimmun US Incorporated, the sole authorized U.S. distributor of T SPOT.TB® reagents and associated kits manufactured by Oxford Immunotec. These reagents are required for tuberculosis testing at VA Western New York Healthcare System (VAWNYHS) Buffalo VA Medical Center (VAMC).
This determination is made in accordance with RFO FAR 12.201-1, Only one responsible source and no other supplies or services will satisfy agency requirements.
The T SPOT.TB® assay is a patented IGRA platform, and its reagents including the antigen panels, controls, and AIM V media are proprietary and FDA cleared only for use with the OEM platform. Oxford Immunotec holds the exclusive patent rights, and Euroimmun US Incorporated is the only supplier legally authorized to provide these FDA approved reagents for federal healthcare facilities. No other vendor can supply reagents that meet FDA, CLIA, CAP, and Joint Commission requirements.
This notice is not a request for competitive quotes. However, interested parties may identify their interest and capability to respond to this requirement by submitting a:
Capability Statement (1 page maximum) Company Name UEI Number Socioeconomic Status Proof of authorization to provide the OEM reagents
Responses must be received no later than 4:00 PM EST on October 16, 2026 to Myra.Green2@va.gov
A determination not to compete this proposed action is solely within the discretion of the Government. Information received will only be considered for determining whether to conduct a competitive procurement in the future.
Prospective contractors must be registered in SAM.gov to be eligible for award.
The Department of Veterans Affairs, Network Contracting Office (NCO) 2, hereby provides notice of its intent to award a sole source, firm fixed price contract to Euroimmun US Incorporated, the sole authorized U.S. distributor of T SPOT.TB® reagents and associated kits manufactured by Oxford Immunotec. These reagents are required for tuberculosis testing at VA Western New York Healthcare System (VAWNYHS) Buffalo VA Medical Center (VAMC).
This determination is made in accordance with RFO FAR 12.201-1, Only one responsible source and no other supplies or services will satisfy agency requirements.
The T SPOT.TB® assay is a patented IGRA platform, and its reagents including the antigen panels, controls, and AIM V media are proprietary and FDA cleared only for use with the OEM platform. Oxford Immunotec holds the exclusive patent rights, and Euroimmun US Incorporated is the only supplier legally authorized to provide these FDA approved reagents for federal healthcare facilities. No other vendor can supply reagents that meet FDA, CLIA, CAP, and Joint Commission requirements.
This notice is not a request for competitive quotes. However, interested parties may identify their interest and capability to respond to this requirement by submitting a:
Capability Statement (1 page maximum) Company Name UEI Number Socioeconomic Status Proof of authorization to provide the OEM reagents
Responses must be received no later than 4:00 PM EST on October 16, 2026 to Myra.Green2@va.gov
A determination not to compete this proposed action is solely within the discretion of the Government. Information received will only be considered for determining whether to conduct a competitive procurement in the future.
Prospective contractors must be registered in SAM.gov to be eligible for award.
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Veterans Affairs → 242-NETWORK Contract Office 02 (36C242)
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS